Maintenance Notice (12:30 AM - 5:30 AM August 24, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 39262-14-1 | Product Number: G0590
Ginsenoside C-K
×
![]()
×
Purity: >95.0%(HPLC)
Synonyms:
- 20(S)-Ginsenoside Ck
- 3β,12β-Dihydroxydammar-24-en-20-yl β-D-Glucopyranoside
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 50MG |
380,00 €
|
1 | ≥40 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | G0590 |
Purity / Analysis Method 
|
>95.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__3__6H__6__2O__8 = 622.88 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 39262-14-1 |
| Reaxys Registry Number | 5785005 |
| PubChem Substance ID | 468591952 |
| MDL Number | MFCD07772261 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Specific rotation | +37.0 to +41.0 deg(C=1,pyridine) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 178 °C |
GHS
Related Laws:
| RTECS# | LZ5776536 |
Transport Information:
| HS Number | 2938909090 |
Application
Ginsenoside C-K: A Major Deglycosylated Metabolite of Ginsenosides, a Traditional Medicine
Ginsenosides are representative pharmaceutical compounds found in various forms in Panax ginseng, a traditional medicinal plant. Then ginsenoside C-K (compound K) is a major deglycosylated metabolite of ginsenosides transformed by intestinal bacterial flora. And it has been demonstrated such diverse intriguing biological properties as anti-carcinogenic, anti-inflammation, anti-allergic, anti-diabetic, anti-angiogenesis, anti-aging, neuroprotective and hepatoprotective effects. (The product is for research purpose only.)
References
- Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng
- Constitutive β-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria
- Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation-The key step of inflammation
- A review of biotransformation and pharmacology of ginsenoside compound K
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.